HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Koichiro Kuwahara Selected Research

Chronic Renal Insufficiency

1/2022Prevention of Contrast-Induced Nephropathy After Cardiovascular Catheterization and Intervention With High-Dose Strong Statin Therapy in Japan　- The PREVENT CINC-J Study.
10/2021Prognostic ability of mid-term worsening renal function after percutaneous coronary intervention: findings from the SHINANO registry.
1/2016Clinical Characteristics and Outcomes of Patients with High Ankle-Brachial Index from the IMPACT-ABI Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Koichiro Kuwahara Research Topics

Disease

53Heart Failure
04/2024 - 05/2003
17Myocardial Infarction
04/2024 - 05/2003
10Stroke (Strokes)
01/2024 - 01/2016
10Cardiomegaly (Heart Hypertrophy)
12/2013 - 10/2003
9Hypertrophy
12/2013 - 02/2002
8Fibrosis (Cirrhosis)
12/2016 - 10/2003
7Coronary Artery Disease (Coronary Atherosclerosis)
01/2024 - 01/2017
6Peripheral Arterial Disease
12/2022 - 11/2017
5Cardiac Arrhythmias (Arrythmia)
04/2024 - 03/2006
5Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 03/2011
4Diabetes Mellitus
11/2023 - 01/2020
4Inflammation (Inflammations)
03/2023 - 01/2017
4Chronic Limb-Threatening Ischemia
11/2022 - 01/2019
4Atrial Fibrillation
07/2022 - 09/2017
4Cardiomyopathies (Cardiomyopathy)
12/2019 - 05/2007
4Sudden Death
01/2016 - 06/2009
4Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
10/2014 - 06/2009
3Ventricular Tachycardia
01/2024 - 05/2013
3Acute Coronary Syndrome
01/2023 - 02/2021
3Hemorrhage
01/2023 - 01/2018
3Ischemia
01/2023 - 01/2003
3Chronic Renal Insufficiency
01/2022 - 01/2016
3Left Ventricular Dysfunction
06/2017 - 11/2005
2Renal Insufficiency (Renal Failure)
10/2023 - 08/2017
2Ischemic Stroke
01/2023 - 11/2021
2Myocardial Ischemia (Ischemic Heart Diseases)
01/2023 - 01/2003
2Frailty
12/2022 - 12/2021
2Anemia
11/2021 - 08/2021
2Thrombosis (Thrombus)
07/2021 - 01/2019
2Amyloidosis
01/2021 - 12/2019
2Body Weight (Weight, Body)
01/2021 - 08/2009
2Hypokalemia
07/2019 - 11/2016
2Death (Near-Death Experience)
02/2019 - 10/2014
2Atherosclerosis
01/2019 - 01/2017
2Infarction (Infarctions)
11/2018 - 05/2003
2Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
02/2018 - 03/2006
2Diabetic Nephropathies (Diabetic Nephropathy)
01/2017 - 01/2016
2Hypertension (High Blood Pressure)
11/2016 - 05/2012
2Chronic Kidney Failure (Chronic Renal Failure)
01/2014 - 01/2012
2Heart Diseases (Heart Disease)
01/2013 - 01/2010
1Anorexia
04/2024
1Malnutrition (Nutritional Deficiencies)
04/2024
1Hyperkalemia
10/2023
1Hypotension (Low Blood Pressure)
10/2023

Drug/Important Bio-Agent (IBA)

24Brain Natriuretic Peptide (Natrecor)FDA Link
01/2023 - 02/2002
11Atrial Natriuretic Factor (ANF)IBA
08/2022 - 10/2003
10Angiotensin IIIBA
01/2020 - 05/2003
8Natriuretic PeptidesIBA
01/2023 - 08/2005
7omega-Chloroacetophenone (Mace)IBA
01/2024 - 01/2016
7pro-brain natriuretic peptide (1-76)IBA
01/2023 - 01/2012
6Biomarkers (Surrogate Marker)IBA
01/2023 - 06/2013
5Type 1 Angiotensin ReceptorIBA
01/2016 - 03/2006
4Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA
01/2023 - 02/2019
4Hemoglobins (Hemoglobin)IBA
01/2023 - 01/2016
4AlbuminsIBA
07/2022 - 01/2017
4Hormones (Hormone)IBA
02/2018 - 02/2002
4RE1-silencing transcription factorIBA
05/2013 - 12/2006
3Proteins (Proteins, Gene)FDA Link
04/2024 - 01/2005
3SodiumIBA
11/2023 - 08/2005
3Sodium-Glucose Transporter 2 InhibitorsIBA
11/2023 - 01/2020
3Serum AlbuminIBA
01/2023 - 01/2020
3Anti-Bacterial Agents (Antibiotics)IBA
05/2022 - 10/2018
3Transcription Factors (Transcription Factor)IBA
01/2019 - 12/2006
3cilnidipineIBA
11/2018 - 10/2014
3NitrendipineIBA
01/2016 - 09/2009
3Messenger RNA (mRNA)IBA
09/2015 - 05/2003
3Guanylate Cyclase-Coupled ReceptorsIBA
08/2009 - 10/2003
3atrial natriuretic factor receptor AIBA
06/2009 - 02/2004
2DiureticsIBA
04/2024 - 10/2022
2Glucose (Dextrose)FDA LinkGeneric
11/2023 - 01/2020
2Sodium-Glucose Transport ProteinsIBA
10/2023 - 10/2020
2AnticoagulantsIBA
01/2023 - 07/2022
2CreatinineIBA
08/2021 - 01/2016
2empagliflozinIBA
10/2020 - 01/2020
2Mineralocorticoid Receptor AntagonistsIBA
10/2020 - 01/2019
2CatecholaminesIBA
11/2019 - 10/2018
2Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIBA
07/2019 - 02/2007
2Apolipoproteins E (ApoE)IBA
01/2019 - 11/2012
2myocardinIBA
01/2019 - 07/2010
2Antihypertensive Agents (Antihypertensives)IBA
11/2016 - 08/2009
2Peptides (Polypeptides)IBA
01/2014 - 06/2013
2CollagenIBA
07/2010 - 08/2009
2TRPC6 Cation ChannelIBA
06/2010 - 12/2006
2CalcineurinIBA
06/2010 - 12/2006
2CytokinesIBA
11/2005 - 01/2005
1esaxerenoneIBA
11/2023
1EnalaprilFDA LinkGeneric
10/2023
1Neprilysin (Neutral Endopeptidase)IBA
10/2023
1sacubitril and valsartan sodium hydrate drug combinationIBA
10/2023
1Angiotensin Receptors (Angiotensin II Receptor)IBA
10/2023
1DobutamineFDA LinkGeneric
10/2023

Therapy/Procedure

15Therapeutics
04/2024 - 05/2012
7Percutaneous Coronary Intervention
01/2024 - 11/2017
6Surgical Amputation (Amputations)
12/2022 - 01/2018
4Renal Dialysis (Hemodialysis)
07/2022 - 01/2014
3Length of Stay
10/2023 - 01/2021
3Catheter Ablation
02/2021 - 01/2019
2Transplantation
04/2024 - 01/2020
2Stents
07/2022 - 07/2021
1Cesarean Section (Caesarean Section)
01/2024